Overview
Product nameHHV8 RF8+ORF65 protein
Protein descriptionRecombinant protein containing fragments: a) QTSSSPTPP GSSSKAPTKP GEEASGPKS V DF, corresponding to N terminal amino acids 32-62 of HSV8 ORF8; and b) A SDILTTLS ST TETAAPA VAD ARKPPS GKKK, corresponding to C terminal amino acids 140-170 of HSV8 ORF65.
Expression hostE. coli
Properties
Purity> 95
% by SDS-PAGE
Purification notesThis protein was purified by proprietary chromatographic techniques.
Biological activityThis protein is immunoreactive with sera of HSV8 infected individuals.
FormLiquid
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferPreservative: None
Constituents: 50% Glycerol, 60mM Sodium chloride, 50mM Tris HCl, 10mM Glutathione
Concentration information loading...
SequenceQTSSSPTPP GSSSKAPTKP GEEASGPKSV DF
Research Areas
Applications
Our Abpromise guarantee covers the use of
ab67704
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|
Application
|
Notes |
| SDS-PAGE |
SDS-PAGE: Use at an assay dependent dilution. |
| ELISA |
ELISA: Use at an assay dependent dilution. |
| WB |
WB: Use at an assay dependent dilution. |
Protein info
RelevanceHHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
References for HHV8 RF8+ORF65 protein (ab67704)
ab67704
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
